Tate & Lyle plc
LSE:TATE

Jigglypop Analysis For Tate & Lyle plc 🤓

Tate & Lyle (GBp 377) sits barely 6% above its 52‑week low (355) and far below the 669 high, signalling a contrarian value play rather than a speculative chase. Price is nudging the 50‑day average (374) but well under the 200‑day (475), implying sentiment is washed‑out after a tough year. With a £1.66bn market cap and resilient, diversified ingredients exposure, the risk/reward skews to recovery if execution steadies. One‑month momentum is modest (+2.6%); day‑to‑day moves are flat. Governance optics: a non‑exec sold ADRs but plans to repurchase in early 2026, tempering concerns. Goldman Sachs has initiated coverage, adding attention, though the target isn’t disclosed here. Bottom line: value‑leaning, not without risk, suited to patient investors awaiting mean reversion this year.

About Tate & Lyle plc 👋

Tate & Lyle plc and its subsidiaries supply ingredients and solutions to the food, beverage, and other industries across North America, Asia, the Middle East, Africa, Latin America, and Europe. The company operates through four segments: Food & Beverage Solutions, Sucralose, Primary Products Europe, and CP Kelco. Its portfolio covers sweeteners, fibres, stabilisers and functional systems, hydrocolloids, as well as starches, proteins, and functional flours. Its products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal care applications. Established in 1903, the company is headquartered in London, United Kingdom.